Walleye Capital’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-697
| Closed | -$7.07K | – | 2109 |
|
|
2024
Q4 | $7.07K | Buy |
+697
| New | +$7.07K | ﹤0.01% | 1903 |
|
|
2023
Q2 | – | Sell |
-3,780
| Closed | -$221K | – | 2486 |
|
|
2023
Q1 | $221K | Sell |
3,780
-6,894
| -65% | -$402K | ﹤0.01% | 1294 |
|
|
2022
Q4 | $544K | Sell |
10,674
-34,237
| -76% | -$1.75M | 0.01% | 962 |
|
|
2022
Q3 | $3.68M | Sell |
44,911
-71,450
| -61% | -$5.85M | 0.07% | 276 |
|
|
2022
Q2 | $7.87M | Buy |
116,361
+110,822
| +2,001% | +$7.5M | 0.22% | 95 |
|
|
2022
Q1 | $612K | Buy |
5,539
+4,612
| +498% | +$510K | 0.02% | 881 |
|
|
2021
Q4 | $89K | Buy |
+927
| New | +$89K | ﹤0.01% | 1654 |
|
|
2020
Q2 | – | Sell |
-1,416
| Closed | -$408K | – | 704 |
|
|
2020
Q1 | $408K | Sell |
1,416
-3,514
| -71% | -$1.01M | 0.09% | 189 |
|
|
2019
Q4 | $1.42M | Buy |
+4,930
| New | +$1.42M | 0.09% | 77 |
|